Short answer: If a US cosmetic procedure uses a medical device in a way that generates tissue plume, the clinic should assess how that plume will be captured and who maintains the evacuation system. An FDA standards record recognizes ISO 16571:2024, a standard on systems for evacuation of plume generated by medical devices. The record explicitly includes cosmetic treatment facilities among settings where such systems may be used. It does not say every laser or IPL service produces plume, that a particular evacuator is cleared, or that purchasing equipment labeled “ISO” solves every airborne-exposure question.
What the FDA record actually establishes
The FDA entry identifies ISO 16571, second edition dated March 2024, and records US recognition on 23 December 2024. The database page was last updated on 28 September 2026. Its public abstract says the standard addresses portable, mobile, stationary and integrated plume evacuation systems. It lists purchasing, design, installation, commissioning, testing, training, use, risk assessment, servicing and maintenance among its subjects. Those categories offer a practical procurement outline even though the full standard text is not reproduced on the FDA page.
The same record identifies boundaries. The standard concerns airborne contamination from plume generated by medical devices; it does not cover all laser safety, room HVAC design, anaesthetic gas scavenging or a general medical-vacuum system. FDA recognition of a consensus standard is not a certificate for a supplier’s actual machine. A buyer should ask for the offered evacuator’s own regulatory status and documentation, and should check whether the proposed aesthetic procedure really creates plume through tissue interaction. A low-level LED session should not be described as a surgical smoke problem on the basis of this source.
A room and purchasing checklist
Start with the procedure, not the catalog. Ask the practitioner whether the planned treatment can generate visible or invisible airborne byproducts, what source-capture approach is appropriate and how the evacuation system will be positioned without impairing clinical work. Record who commissions and tests it, who replaces filters or consumables, and who responds to a failure during a session. Compare the supplier’s installation and maintenance instructions with the room’s actual layout and workflow. The FDA record names these subjects but does not prescribe one universal flow rate, filter model or distance for every cosmetic procedure.
Include the evacuation system in the total cost of ownership if the procedure warrants one. A device that is never maintained, lacks replacement parts or is too awkward for staff to use will not serve the intended work pattern. Ask whether the model is portable or integrated and whether its status changes when paired with a different handpiece or procedure. Keep any patient safety, worker exposure and infection-control assessments in their own appropriate files; plume management is one part of a wider safety program.
Limits
This article uses the FDA’s public recognition record, not the complete ISO text and not a clinical protocol. It is not a claim that any TUOKE device creates plume, includes an evacuator or meets ISO 16571. The 2026 database update is a record update, not proof of a new clinical finding. Qualified clinical, occupational-safety and regulatory advisers should assess the exact procedure and equipment before a clinic selects controls.
More purchasing context is in TUOKE’s optical aesthetic equipment insights.
Source
US Food and Drug Administration, recognition record for ISO 16571:2024, recognition dated 23 December 2024, page updated 28 September 2026; reviewed 15 October 2026.